SREBF1 and coronary artery disorder: Cluster 0 bears the thematic congregation identified as ‘Therapeutic Potential and Research Advances in Traditional Chinese Medicine and Cyberpharmacology.’ Concentrated within this group is a collection of articles devoting attention to the potential operative pathways of traditional Chinese medicine in managing coronary artery disease, spanning the SREBP1 pathway, the manipulation of intestinal flora, and the moderation of lipid metabolic processes.